C WorldWide Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-91,848
Closed -$11.9M 101
2019
Q1
$11.9M Hold
91,848
0.15% 35
2018
Q4
$10.6M Hold
91,848
0.15% 38
2018
Q3
$9.86M Hold
91,848
0.13% 41
2018
Q2
$7.84M Sell
91,848
-33,272
-27% -$2.73M 0.11% 48
2018
Q1
$9.68M Hold
125,120
0.15% 41
2017
Q4
$10.6M Hold
125,120
0.15% 45
2017
Q3
$10.7M Sell
125,120
-5,364
-4% -$440K 0.15% 43
2017
Q2
$10.7M Sell
130,484
-13,511
-9% -$1.1M 0.16% 46
2017
Q1
$12.1M Hold
143,995
0.21% 42
2016
Q4
$10.6M Buy
143,995
+136,895
+1,928% +$10.2M 0.2% 38
2016
Q3
$570K Hold
7,100
0.01% 120
2016
Q2
$560K Hold
7,100
0.01% 106
2016
Q1
$511K Hold
7,100
0.01% 111
2015
Q4
$598K Hold
7,100
0.01% 121
2015
Q3
$594K Buy
+7,100
New +$599K 0.01% 122

Other funds holding LLY

C WorldWide Group's LLY Position: Q2 2019 in Review

C WorldWide Group sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 91,848 shares — an estimated $11.9M sold.

C WorldWide Group first reported a position in LLY in Q3 2015 and held it in 15 quarters. The position peaked at $12.1M in Q1 2017. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • C WorldWide Group reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 91,848 Eli Lilly shares in Q2 2019, an estimated $11.9M.
  • C WorldWide Group first reported a position in Eli Lilly in Q3 2015 and held it in 15 quarters.
  • C WorldWide Group's Eli Lilly position peaked at $12.1M in Q1 2017.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.